France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to […]
Olympus Corporation (“Olympus”) hereby announces that the closing date of the transfer of all shares of Evident Corporation, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) (the “Transfer”) has been scheduled for April 3, […]
Calibre Scientific Acquires SciQuip, a UK Provider of Scientific Equipment, Supplies and Services LOS ANGELES, CA — Calibre Scientific is pleased to announce the acquisition of SciQuip Ltd, a UK based provider of scientific equipment, laboratory supplies and services to customers in the research, university, hospital and biopharma sectors. SciQuip marks Calibre Scientific’s 12th acquisition […]
Today, LGC announced the acquisition of Lipomed AG’s reference materials business including standards with drugs of abuse and toxicology applications, and thus greatly complementing LGC’s reference standards offering. Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference […]
PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined […]
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between two leading global life sciences companies follows several […]
INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time savings to academic, research and diagnostics laboratories using NGS and, ultimately, accelerating discovery in […]
Transforms into new Life Sciences and Diagnostics company WALTHAM, Mass. — PerkinElmer Inc. (NYSE: PKI), today announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital, a growth-oriented investment firm. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering novel scientific […]
LOS ANGELES — Calibre Scientific is pleased to announce the acquisition of AlphaScience GmbH (“AlphaScience” or the “Company”), a diagnostics provider with headquarters in Frankfurt, Germany. AlphaScience will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific, enhancing its sales capabilities and product range for customers in the DACH region. AlphaScience is a […]
Acquisition will make electron capture dissociation (ECD) technology available to more biopharma researchers and labs globally SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass spectrometers that […]
Pay Invoice
Latest Blogs
-
Dividends as an Indicator for Laboratory Tool Industry Companies in 2022
February 1, 2023 9:00 am
-
Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
January 5, 2023 9:13 pm
-
Danaher Investor Day 2022 Showcases Big Announcements and Focuses on Cytiva
September 27, 2022 5:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
